TipRanks
Go Ultimate55% OFF

Lytix Biopharma AS (6BG) Income Statement

Lytix Biopharma AS Income Statement

Last quarter (Q2 2026), Lytix Biopharma AS's total revenue was $0.00. In Q2, Lytix Biopharma AS's net income was $-26.67M. See Lytix Biopharma AS’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 11.13M$ 3.99M$ 11.03M$ 19.31M
$ -1.00M$ -23.46M$ 3.99M$ 11.03M$ 19.31M
$ 67.65M$ 77.17M$ 100.78M$ 76.70M$ 67.29M
Depreciation and Amortization$ 1.00M$ 915.00K$ 962.00K$ 919.00K$ 453.00K
$ -63.02M$ -93.22M$ -86.88M$ -54.91M$ -47.56M
$ -68.65M$ -95.90M$ -96.78M$ -65.67M$ -47.98M
$ 8.67M$ 6.37M$ 8.89M$ 9.60M$ -94.00K
$ -59.98M$ -94.27M$ -87.90M$ -56.07M$ -48.08M
$ -59.98M$ -94.27M$ -87.90M$ -56.07M$ -48.08M
Per Share Metrics
Basic EPS$ -0.88$ -1.74$ -2.19$ -1.41$ -1.45
Diluted EPS$ -0.88$ -1.74$ -2.19$ -1.41$ -1.45
Weighted Average Shares Outstanding68.53M54.13M40.07M39.67M38.74M
Weighted Average Shares Outstanding (Diluted)68.53M54.13M40.07M39.67M38.74M

Currency in NOK

Lytix Biopharma AS Earnings and Revenue History

-100M-50M050M-1500000 %-1000000 %-500000 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin